Literature DB >> 29620664

Adult renal neuroblastoma: A case report and literature review.

Ming-De Huang1, Li-Sheng Hsu, Huei-Chieh Chuang, Wei-Yu Lin, Wei-Hsiu Lin, Chih-Wei Yen, Min-Lang Chen.   

Abstract

RATIONALE: Adult renal neuroblastoma (NB) is extremely rare, and there have been only a few cases previously described in the literature. We report a case of adult renal NB and summarize the clinical and imaging features of the reported cases. PATIENT CONCERNS: A 41-year-old female was admitted to our hospital with a chief complaint of gross hematuria that had persisted for a month. Nonenhanced computed tomography (CT) revealed a hypodense right renal mass without calcification. Enhanced CT showed an infiltrative, heterogeneously enhancing right renal mass with retrocaval lymphadenopathy and right renal vein thrombus. Magnetic resonance imaging (MRI) revealed that the right renal mass was isointense relative to the renal parenchyma on nonenhanced T1-weighted images; it showed mixed hypointensity and hyperintensity on T2-weighted images, and heterogeneous enhancement with a hyperintense rim on fat-saturated, enhanced T1W images. The initial impression was renal cell carcinoma (RCC). DIAGNOSES: Adult renal neuroblastoma.
INTERVENTIONS: Right nephroureterectomy with lymph node dissection was performed. The pathology and immunohistochemistry confirmed the diagnosis of renal NB with retrocaval lymphadenopathy and retroperitoneal metastasis. OUTCOMES: After surgery, the patient received 6 courses of chemotherapy, and no recurrence was observed during a 24-month follow-up period. LESSONS: The clinical picture of adult renal NB is that of a 44-year-old woman, presenting with an abdominal or renal mass about 13cm in size, accompanied by hypertension, hematuria, or pain. In contrast to CT features described in previous literature, no tumor calcification is mentioned in these adult renal NB cases. It is difficult to differentiate renal NB from RCC based on CT or MRI. However, biopsy, urinary catecholamine levels, and metaiodobenzylguanidine (MIBG) scan may aid in presurgical diagnosis.

Entities:  

Mesh:

Year:  2018        PMID: 29620664      PMCID: PMC5902279          DOI: 10.1097/MD.0000000000010345

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


Introduction

Neuroblastoma (NB) is typically a tumor of early childhood; more than 90% of cases occur in individuals younger than 10 years of age, and adults are rarely affected.[ Adult renal NB is even rarer, and only 7 cases have been reported in the previous literature.[ We report a case of adult renal NB and summarize the clinical and imaging features of the reported cases.

Case report

A previously healthy 41-year-old female visited our outpatient department in December 2015 with a chief complaint of gross hematuria that had persisted for a month. The physical examination did not show any abnormality. Urine cytology did not reveal malignancy. The patient had no history of hypertension. Non-enhanced computed tomography (CT) (Somatom Sensation 64; Siemens Health Care, Forchheim, Germany) revealed an infiltrative right renal mass (7.8 × 7.5 × 5.2 cm) isodense to the renal parenchyma, and no presence of calcification. The right renal mass showed heterogeneous enhancement and extracapsular extension into the perirenal space on enhanced images. Confluent retrocaval lymphadenopathy was also observed. A tumor thrombus was noted in the right renal vein (Fig. 1). Magnetic resonance imaging (MRI) (MAGNETOM Verio, Siemens Healthcare, Erlangen, Germany) revealed that the right renal mass was isointense relative to the renal parenchyma on nonenhanced T1W images (T1WI); it showed mixed hypointensity and hyperintensity relative to the renal parenchyma on T2W images (T2WI), and heterogeneous enhancement with a hyperintense rim on fat-saturated, enhanced T1W images (Fig. 2). The initial impression was renal cell carcinoma (RCC) with renal vein thrombus and regional lymphadenopathy. Urinary catecholamine levels were not measured.
Figure 1

Computed tomography of the abdomen. (A) Axial nonenhanced image reveals isodense right renal mass without calcification (arrowhead). (B) Axial enhanced image reveals right infiltrative renal mass with heterogeneous enhancement (arrowhead). (C) Axial enhanced image shows tumor thrombus in right renal vein (open arrowhead). There is confluent lymphadenopathy in retrocaval region (arrowhead). (D) Coronal delayed-phase image reveals the right renal mass (arrowhead) and retrocaval lymphadenopathy (open arrowhead).

Figure 2

Magnetic resonance imaging of the abdomen. (A) Axial nonenhanced T1-weighted image reveals the right renal mass isointense to renal parenchyma (arrowhead). (B) Axial T2-weighted image reveals the right renal tumor has heterogeneous, mixed hypointensity, and hyperintensity (arrowhead). (C, D) Axial enhanced, fat-saturated, T1-weighted image shows the right renal mass (arrowheads), and lymphadenopathy (open arrowheads) have heterogeneous enhancement and hyperintense rim.

Computed tomography of the abdomen. (A) Axial nonenhanced image reveals isodense right renal mass without calcification (arrowhead). (B) Axial enhanced image reveals right infiltrative renal mass with heterogeneous enhancement (arrowhead). (C) Axial enhanced image shows tumor thrombus in right renal vein (open arrowhead). There is confluent lymphadenopathy in retrocaval region (arrowhead). (D) Coronal delayed-phase image reveals the right renal mass (arrowhead) and retrocaval lymphadenopathy (open arrowhead). Magnetic resonance imaging of the abdomen. (A) Axial nonenhanced T1-weighted image reveals the right renal mass isointense to renal parenchyma (arrowhead). (B) Axial T2-weighted image reveals the right renal tumor has heterogeneous, mixed hypointensity, and hyperintensity (arrowhead). (C, D) Axial enhanced, fat-saturated, T1-weighted image shows the right renal mass (arrowheads), and lymphadenopathy (open arrowheads) have heterogeneous enhancement and hyperintense rim. Right nephroureterectomy with lymph node dissection was performed. The pathology revealed a renal mass with a grayish white, soft texture, and vascular invasion. The enlarged retrocaval lymph nodes were attached to the adrenal gland without invasion. Metastasis in the retroperitoneum was also noted. Microscopically, the tumor was chiefly composed of undifferentiated cells in a fibrillary background. Focal immature neuroepithelial (neural tube-like structures) and ganglionic differentiation was observed (Fig. 3A). The differential diagnosis included nephroblastoma (Wilms tumor), Ewing sarcoma, NB, and primary or metastatic germ cell tumor with predominant immature neuroepithelial element with sarcomatous differentiation. Immunohistochemically, undifferentiated tumor cells were negative for CD45, PAX8, GATA3, CD99, and WT1. The fibrillary background and ganglion cells showed expression of synaptophysin (Fig. 3B), chromogranin A, and neuropil, allowing exclusion of the possibilities of Wilms tumor and Ewing sarcoma. Therefore, NB was the most suitable diagnosis.
Figure 3

Pathology and immunohistochemistry of renal mass. (A) Undifferentiated cells in fibrillary background with neural tubule-like structures forming (H&E, ×200). Ganglionic differentiation (arrow) was also focally identified (enlarged in left lower corner of figure, ×400). (B) Synaptophysin antibodies highlighted fibrillar background of tumor (×200).

Pathology and immunohistochemistry of renal mass. (A) Undifferentiated cells in fibrillary background with neural tubule-like structures forming (H&E, ×200). Ganglionic differentiation (arrow) was also focally identified (enlarged in left lower corner of figure, ×400). (B) Synaptophysin antibodies highlighted fibrillar background of tumor (×200). After surgery, 6 courses of chemotherapy with cisplatin (60 mg/m2 on day 1), doxorubicin (30 mg/m2 on day 2), etoposide (80 mg/m2 on days 2, 5), and cyclophosphamide (750 mg/m2 on days 3, 4) were administered. No evidence of recurrence was observed during a 24-month follow-up period. The case report has been approved by the Chang Gung Medical Foundation Institutional Review Boards (IRB), Taipei, Taiwan. The patient consent was waivered by the IRB.

Discussion

NB is a rare tumor in the adult population. Intrarenal NB is extremely rare. We collected all published cases (n = 8) of adult renal NB in Table 1, and summarized features of these cases are shown in Table 2. While only a few case reports exist, adult renal NB displays a female (75%) and right-sided (62.5%) predominance. The onset of age is about 44.00 ± 18.12 years. The maximal diameter of the mass is 12.94 ± 8.12 cm. Initial symptoms include: hematuria, abdominal mass, renal mass, pain, and hypertension. The sites of distant metastasis are liver, bone, lung, and pelvic lymph nodes.
Table 1

All published cases of adult renal neuroblastoma and present case.

Table 2

Summary table of reported cases of adult renal neuroblastoma (n = 8).

All published cases of adult renal neuroblastoma and present case. Summary table of reported cases of adult renal neuroblastoma (n = 8). According to the International Neuroblastoma Staging System (INSS), half of the cases were stage 4 at initial presentation (n = 4). In 4 cases (57.14%; case 7 had no report of outcome), long-term disease-free survival (18 months–5 years) was achieved, including 3 cases of stage 1 and 1 case of stage 4 disease. Fan[ reported that the features of pediatric renal NB include: male predominance; average age of onset of 17 months; typical presentation with an abdominal mass and hypertension; and possibly elevated urinary catecholamine levels. Table 3 shows a comparison of features between adult and pediatric renal NB.
Table 3

Comparison between pediatric and adult renal neuroblastoma.

Comparison between pediatric and adult renal neuroblastoma. Image features of adult renal NB have been described in previous reports. The CT findings include: isodense renal mass without calcification on nonenhanced CT; heterogeneously enhancing mass with central necrosis after contrast medium injection, associated with perirenal invasion, regional lymphadenopathy, or renal vein thrombosis. The MRI findings include: isointense to hypointense renal mass on T1WI; heterogeneous, mixed hypointense and hyperintense renal mass on T2WI; and heterogenous enhancement with a hyperintense rim. Lonergan et al[ reported that approximately 80% to 90% of NBs demonstrate calcification on CT scans; however, none of the adult renal NB cases reported demonstrated renal calcification. According to these findings, it is difficult to differentiate renal NB from RCC based on CT or MRI features. Other modalities, however, may be helpful in the differentiation of NB. Ninety percent of NB cases show elevated blood or urinary catecholamine levels. Catecholamine metabolites such as vanillylmandelic acid, homovanillic acid, and dopamine can aid in the diagnosis of NB and have been used in clinical diagnosis and early detection.[ However, most patients with adult renal NB did not receive these tests because the lesions were mistaken for RCC. Fine needle aspiration cytology and core needle biopsy can provide accurate diagnosis prior to surgery. Frostad et al[ reported that fine needle aspiration cytology with immunohistochemistry, in combination with elevated urinary catecholamine levels, can offer an accurate diagnosis of neuroblastic tumors in children. Mandelia et al[ stated that fine needle aspiration cytology of NB can provide sufficient material for molecular genetic analyses. Mullassery et al[ reported that core biopsy with an 18G needle appeared to provide adequate tissue sampling for diagnosis, risk classification, and tumor staging. Metaiodobenzylguanidine (MIBG) is structurally similar to norepinephrine, and can be used for localization of neural crest tumors. The specificity of MIBG scintigraphy for NB detection approaches 100%, and the sensitivity has been reported to be 90% to 95%.[ MIBG scintigraphy was reported to be more specific and superior to 18F-fluorodeoxyglucose positron emission tomography (FDG-PET). Thus, the primary role of FDG-PET lies in identifying those NBs that do not demonstrate MIBG uptake. However, approaches using newer tracers, such as 11carbon labeled hydroxyephedrine and 11C-epinephrine PET, have also been studied.[

Conclusion

Adult renal NB is extremely rare, and we summarize the clinical and imaging features based on the cases reported in the literature. The clinical picture of adult renal NB is that of a woman of 44 years of age, presenting with an abdominal or renal mass about 13 cm in size, accompanied by hypertension, hematuria, or pain. In contrast to the CT features reported in the previous literature, no tumor calcification was observed in these adult renal NB cases. It is difficult to differentiate renal NB from RCC based on presurgical CT or MRI. However, biopsy, urinary catecholamine levels, and MIBG scan may aid in the diagnosis prior to surgery.

Author contributions

Investigation: W.-Y. Lin. Supervision: L.-S. Hsu. Writing – original draft: H.-C. Chuang, M.-D. Huang. Writing – review & editing: C.-W. Yen, H.-C. Chuang, L.-S. Hsu, M.-L. Chen, W.-H. Lin, W.-Y. Lin.
  15 in total

1.  Neuroblastoma presenting as renal cell carcinoma in an adult.

Authors:  G C Baumgartner; J Gaeta; Z Wajsman; C Merrin
Journal:  Urology       Date:  1975-09       Impact factor: 2.649

2.  Primary renal neuroblastoma in adults.

Authors:  Albert Tiu; Edward Latif; Leanne Yau; Roisin Reynolds; Ewan K A Millar; Peter Aslan
Journal:  Urology       Date:  2013-05-21       Impact factor: 2.649

3.  Assessment of fine needle aspiration cytology samples for molecular genetic analysis in neuroblastoma.

Authors:  Ankur Mandelia; Sandeep Agarwala; Arundhati Sharma; Venkateswaran K Iyer; Veereshwar Bhatnagar
Journal:  Pediatr Surg Int       Date:  2013-11       Impact factor: 1.827

4.  A rare adult renal neuroblastoma better imaged by 18F-FDG than by 68Ga-dotanoc in the PET/CT scan.

Authors:  Tarun Kumar Jain; Sharwan Kumar Singh; Ashwani Sood; Abhiram Gj Ashwathanarayama; Rajender Kumar Basher; Jaya Shukla; Bhagwant Rai Mittal
Journal:  Hell J Nucl Med       Date:  2017-03-20       Impact factor: 1.102

5.  Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.

Authors:  Volker Strenger; Reinhold Kerbl; Hans Jürgen Dornbusch; Ruth Ladenstein; Peter F Ambros; Inge M Ambros; Christian Urban
Journal:  Pediatr Blood Cancer       Date:  2007-05       Impact factor: 3.167

6.  Adult intrarenal neuroblastoma presenting as renal cell carcinoma.

Authors:  Omer Bayrak; Ilker Seckiner; Sakip Erturhan; Abdullah Aydin; Faruk Yagci
Journal:  Can Urol Assoc J       Date:  2012-08       Impact factor: 1.862

7.  Primary renal neuroblastoma--a clinical pathologic study of 8 cases.

Authors:  Rong Fan
Journal:  Am J Surg Pathol       Date:  2012-01       Impact factor: 6.394

Review 8.  MIBG and somatostatin receptor analogs in children: current concepts on diagnostic and therapeutic use.

Authors:  Farzana D Pashankar; M Sue O'Dorisio; Yusuf Menda
Journal:  J Nucl Med       Date:  2005-01       Impact factor: 10.057

9.  Surgical resection and post-operative radiotherapy in an adult renal neuroblastoma patient with multiple bone and joint metastases: A case report.

Authors:  Qiu-Long Liu; Qi-Lian Liang; Wen-Ting Ou; Zhou-Yu Li; Xiang-Ning Zhang
Journal:  Oncol Lett       Date:  2015-04-09       Impact factor: 2.967

10.  The clinical use of fine needle aspiration cytology for diagnosis and management of children with neuroblastic tumours.

Authors:  B Fröstad; E Tani; P Kogner; S Maeda; O Björk; L Skoog
Journal:  Eur J Cancer       Date:  1998-03       Impact factor: 9.162

View more
  3 in total

1.  Primary thoracic neuroblastoma in an adult: A rare case report.

Authors:  Yan-Bin Tan; Jin-Fan Li; Wen-Shan Li; Run-Lin Yang
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

2.  Metastatic adult neuroblastoma with spontaneous tumor lysis syndrome.

Authors:  Tarsila Vieceli; Ana Laura Jardim Tavares; Renata Pibernat de Moraes; Gustavo Adolpho Moreira Faulhaber
Journal:  Autops Case Rep       Date:  2020-09-02

3.  Bioprinted Cancer Model of Neuroblastoma in a Renal Microenvironment as an Efficiently Applicable Drug Testing Platform.

Authors:  Dongwei Wu; Johanna Berg; Birte Arlt; Viola Röhrs; Munir A Al-Zeer; Hedwig E Deubzer; Jens Kurreck
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.